SCHEMBL1008469

SCHEMBL1008469

CN1[C]N(C)c2c1c(=O)n(C)c(=O)n2C

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ ADORA2A P29274 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4058851 0.65 KMT2A (0.33) ADORA2A
Iodide SCHEMBL1609671 0.64 KMT2A (0.32) ADORA2A
SCHEMBL15214970 0.64 KMT2A (0.31) ADORA2A
SCHEMBL3192497 0.63 KDM4E (0.30) —
SCHEMBL141994 0.59 GSK3A (0.44) ADORA2A
SCHEMBL7532405 0.55 ALDH1A1 (0.40) ADORA2A
SCHEMBL10724834 0.55 POLB (0.36) ADORA2A
SCHEMBL21891275 0.54 ALDH1A1 (0.33) ADORA2A
SCHEMBL7083772 0.54 GSK3A (0.39) ADORA2A
SCHEMBL13024384 0.54 ADORA2A (0.41) ADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2268652-B1 PLATINUM-N-HETEROCYCLIC CARBENE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF SANOFI SA (FR) 2012-12-19 — — EP disclosed
EP-2268652-A2 PLATINUM-N-HETEROCYCLIC CARBENE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF Sanofi-Aventis (FR) 2011-01-05 — — EP disclosed
WO-2009118475-A2 PLATINUM-N-HETEROCYCLIC CARBENE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF SANOFI-AVENTIS (FR) 2009-10-01 — — WO disclosed
Send feedback